Task: Answer Verification
Input (English): Question: Are intensive peri-operative use of factor VIII and the Arg593 -- > Cys mutation risk factors for inhibitor development in mild/moderate hemophilia A?
Answer: The Arg593Cys genotype and intensive peri-operative use of FVIII, especially when administered by continuous infusion, are associated with an increased risk for inhibitor development in mild/moderate hemophilia A.
Output (English): yes